It’s Not Over Yet: The Ongoing Impact of COVID-19 for Those with CLL / SLL
Recorded Wednesday, August 24, 2022
Description:
As much of the world has seemingly moved on from COVID-19 despite the ongoing global health emergency, the virus continues to pose serious risks for those who are immunocompromised. However, as more options for protection and treatment are being developed, we remain hopeful for the future! Infectious disease specialist, Dr. Shmuel Shoham, will briefly present some of the newest clinical updates and guidance, with the remainder of the event being dedicated to answering audience questions about COVID-19 and CLL / SLL.
Moderator
Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd
Executive Vice President and Chief Medical Officer
CLL Society
Speaker
Shmuel Shoham, MD
Professor of Clinical Medicine
Johns Hopkins University School of Medicine
Speaker
Robyn Brumble, MSN, RN
Director of Scientific Affairs and Research
CLL Society
CLL Society Resources
- Download Slides
- Audience Questions and Answers
- COVID-19 Webpage
- COVID-19 Plan: Checklists for Chronic Lymphocytic Leukemia (CLL) Preparing for Pre and Post COVID-19 Exposure
- Monoclonal Antibodies for CLL and Other High-Risk Patients Who Test Positive for COVID-19
- Answering the Most Common Questions About COVID-19 Booster Doses and Evusheld for Those with CLL / SLL
- CLL Society’s Official COVID-19 Triage Statement
- CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies
- The Most Recent COVID-19 Vaccination Schedule for CLL / SLL Patients
- Sign up for CLL Society Weekly Emails
- CLL Society Support Groups
Virtual Exhibit Resources
This program was made possible by grant support from AstraZeneca, BeiGene, Bristol Myers Squibb, Pharmacyclics, and Janssen.
